OCULUS Keratograph 5M debuts colour to topography!

Article

Keratograph 5M technology is a revolution in corneal topography and dry eye analysis. The high-resolution colour camera and the integrated magnification changer offer a new perspective on the tear film assessment procedure.

The new Keratograph 5M is the perfect tool for topography and advanced external imaging for dry eye screening.

  • High-resolution colour camera and magnification changer
  • Imaging of the upper and lower meibomian glands
  • Non-invasive tear film break up time and tear meniscus height measurements
  • Assessment of the lipid layer and tear film particles
  • Grading of the bulbar redness
  • Image and video documentation

The high-resolution colour camera and the integrated magnification changer of the OCULUS Keratograph 5M offer a new perspective on the tear film assessment procedure.

The Keratograph 5M provides the ideal illumination for every application: white diodes for the assessment of tear film particles movement, blue diodes for fluorescein imaging, infrared diodes for meibography and white annular illumination is used to precisely measure thousands of points on the surface of the cornea.

In addition to these unique features the Keratograph 5M measures corneal topography precisely. The built-in real keratometer and automatic measurement activation guarantee perfect reproducibility of K values. Tear film break-up time measurement with the Keratograph 5M is touch-free and fully automatic.

Integrate the Keratograph 5M into your practice as an active patient consultation tool. Thanks to many visual maps and easy to understand diagrams the Keratograph 5M enhances communication with your patients.

Further information may be found here.

Company DetailsE-mail: export@oculus.deWebsite: www.oculus.de

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Related Content
© 2025 MJH Life Sciences

All rights reserved.